Nevada Administrative Code
Chapter 639 - Pharmacists and Pharmacy
TRADE PRACTICES
Section 639.7105 - Electronic transmission of prescription
Current through September 16, 2024
Except as otherwise provided in NAC 639.648 and 639.711:
1. A prescription for a dangerous drug may be transmitted to a pharmacy electronically by a practitioner or, if the prescription is for a dangerous drug, the designated agent of the practitioner, if the patient:
2. A practitioner shall not transmit a prescription for a controlled substance to a pharmacy electronically unless:
3. The designated agent of a practitioner shall not transmit a prescription for a dangerous drug to a pharmacy electronically unless:
4. If the designated agent of a practitioner transmits a prescription electronically to a pharmacy, the practitioner shall review the electronic prescription file not later than 24 hours after the electronic transmission.
5. In addition to the requirements set forth in NRS 639.2353, 639.23535 and 639.2589, a prescription that is transmitted electronically to a pharmacy must include:
6. In addition to the requirements set forth in subsection 5 and NRS 639.2353, 639.23535 and 639.2589, a prescription for a controlled substance that is transmitted electronically to a pharmacy must include:
7. A pharmacist who receives a prescription that is transmitted electronically shall keep a paper or electronic copy of the prescription for at least 2 years after the pharmacist receives the prescription. The copy of the prescription that is kept must be readily accessible to:
8. A pharmacist shall not dispense a prescription that is transmitted electronically until the pharmacist determines that the prescription complies with the requirements of state and federal law.
9. A prescription that is transmitted and complies with the provisions of this section shall be deemed an original prescription.
10. The Board may suspend the privilege of a practitioner to transmit prescriptions electronically or take any other appropriate action if the Board reasonably suspects that the practitioner or the designated agent of the practitioner has transmitted a prescription electronically that is:
Added to NAC by Bd. of Pharmacy, eff. 11-14-97; A by R164-01, 12-17-2001; R160-10, 5-5-2011; R176-12, 12-20-2012; A by R119-13, eff. 3/28/2014; A by R146-17AP, eff. 5/16/2018; A by R083-20A, eff. 12/29/2020
NRS 639.070, 639.23535